Gilead Sciences, Inc. (GILD)
Data as of August 11, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 4/5 metrics rated Sunny
What does Gilead Sciences, Inc. do?
🏢 Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines to meet medical needs worldwide. 🌎 They're headquartered in Foster City, California, and offer a range of innovative products for HIV/AIDS, coronavirus, liver diseases, and more. 💊🔬 With collaborations that fuel their groundbreaking research, Gilead is dedicated to improving the lives of patients in need.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $133.06 | Market Cap | — |
| Exchange | NASDAQ Global Select | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Gilead Sciences, Inc. has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
Are they building the future?
Revenue and earnings are trending upward — Gilead Sciences, Inc. appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.